MYC and cancer: Overexpression of LAPTM4B-35 could activate some proto-oncogenes, such as c-myc, c-jun and c-fos [35], and promote proliferation, migration, and invasion in some human cancer lines which would enhance the growth and metastasis of HCC xenografts in nude mice [36].